Literature DB >> 13617598

Persistent excretion of pyrimethamine following oral administration.

C C SMITH, J IHRIG.   

Abstract

Entities:  

Keywords:  ANTIMALARIALS/metabolism

Mesh：

Substances：

Year:  1959        PMID： 13617598     DOI： 10.4269/ajtmh.1959.8.60

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


× No keyword cloud information.
  6 in total

1.  Falciparum malaria cured by quinine followed by sulfadoxine-pyrimethamine.

Authors:  A P Hall; E B Doberstyn; V Mettaprakong; P Sonkom
Journal:  Br Med J       Date:  1975-04-05

2.  Salivary elimination of pyrimethamine.

Authors:  R A Ahmad; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1981-01       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of antimalarial drugs.

Authors:  N J White
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

4.  Pharmacokinetic properties of sulfadoxine-pyrimethamine in pregnant women.

Authors:  Harin A Karunajeewa; Sam Salman; Ivo Mueller; Francisca Baiwog; Servina Gomorrai; Irwin Law; Madhu Page-Sharp; Stephen Rogerson; Peter Siba; Kenneth F Ilett; Timothy M E Davis
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

5.  Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine.

Authors:  R A Ahmad; H J Rogers
Journal:  Br J Clin Pharmacol       Date:  1980-11       Impact factor: 4.335

6.  Continuous-flow automation of the Lactobacillus casei serum folate assay.

Authors:  G B Tennant
Journal:  J Clin Pathol       Date:  1977-12       Impact factor: 3.411
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.